[GENM] QoQ Quarter Result on 30-Jun-2022 [#2]
Announcement Date
25-Aug-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
30-Jun-2022 [#2]
Profit Trend
QoQ- 91.42%
YoY- 96.88%
Quarter Report
View:
Show?
| Quarter Result | |||||||||
| 31/03/23 | 31/12/22 | 30/09/22 | 30/06/22 | 31/03/22 | 31/12/21 | 30/09/21 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,283,487 | 2,434,658 | 2,271,412 | 2,175,626 | 1,721,299 | 1,889,177 | 826,269 | 97.05% | |
| PBT | 41,290 | -372,420 | 95,672 | 50,620 | -116,072 | 162,275 | -379,215 | - | |
| Tax | -86,699 | -96,564 | -103,935 | -92,896 | -31,791 | -38,195 | 72,168 | - | |
| NP | -45,409 | -468,984 | -8,263 | -42,276 | -147,863 | 124,080 | -307,047 | -72.06% | |
| - | |||||||||
| NP to SH | -27,379 | -393,969 | 11,376 | -10,852 | -126,527 | 174,119 | -289,247 | -79.26% | |
| - | |||||||||
| Tax Rate | 209.98% | - | 108.64% | 183.52% | - | 23.54% | - | - | |
| Total Cost | 2,328,896 | 2,903,642 | 2,279,675 | 2,217,902 | 1,869,162 | 1,765,097 | 1,133,316 | 61.70% | |
| - | |||||||||
| Net Worth | 12,237,759 | 12,633,411 | 12,974,709 | 13,199,931 | 13,118,196 | 13,793,793 | 13,624,198 | -6.91% | |
| Dividend | |||||||||
| 31/03/23 | 31/12/22 | 30/09/22 | 30/06/22 | 31/03/22 | 31/12/21 | 30/09/21 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|
| Div | - | 509,868 | - | 339,912 | - | 508,787 | - | - | |
| Div Payout % | - | 0.00% | - | 0.00% | - | 292.21% | - | - | |
| Equity | |||||||||
| 31/03/23 | 31/12/22 | 30/09/22 | 30/06/22 | 31/03/22 | 31/12/21 | 30/09/21 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|
| Net Worth | 12,237,759 | 12,633,411 | 12,974,709 | 13,199,931 | 13,118,196 | 13,793,793 | 13,624,198 | -6.91% | |
| NOSH | 5,938,040 | 5,938,040 | 5,938,040 | 5,938,040 | 5,938,040 | 5,938,040 | 5,938,040 | 0.00% | |
| Ratio Analysis | |||||||||
| 31/03/23 | 31/12/22 | 30/09/22 | 30/06/22 | 31/03/22 | 31/12/21 | 30/09/21 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|
| NP Margin | -1.99% | -19.26% | -0.36% | -1.94% | -8.59% | 6.57% | -37.16% | - | |
| ROE | -0.22% | -3.12% | 0.09% | -0.08% | -0.96% | 1.26% | -2.12% | - | |
| Per Share | |||||||||
| 31/03/23 | 31/12/22 | 30/09/22 | 30/06/22 | 31/03/22 | 31/12/21 | 30/09/21 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|
| RPS | 40.30 | 42.98 | 40.09 | 38.40 | 30.44 | 33.42 | 14.62 | 96.71% | |
| EPS | -0.48 | -6.95 | 0.20 | -0.19 | -2.24 | 3.08 | -5.12 | -79.39% | |
| DPS | 0.00 | 9.00 | 0.00 | 6.00 | 0.00 | 9.00 | 0.00 | - | |
| NAPS | 2.16 | 2.23 | 2.29 | 2.33 | 2.32 | 2.44 | 2.41 | -7.04% | |
| Adjusted Per Share Value based on latest NOSH - 5,938,040 | |||||||||
| 31/03/23 | 31/12/22 | 30/09/22 | 30/06/22 | 31/03/22 | 31/12/21 | 30/09/21 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|
| RPS | 40.28 | 42.95 | 40.07 | 38.38 | 30.36 | 33.33 | 14.58 | 97.01% | |
| EPS | -0.48 | -6.95 | 0.20 | -0.19 | -2.23 | 3.07 | -5.10 | -79.33% | |
| DPS | 0.00 | 8.99 | 0.00 | 6.00 | 0.00 | 8.98 | 0.00 | - | |
| NAPS | 2.1587 | 2.2285 | 2.2887 | 2.3285 | 2.3141 | 2.4332 | 2.4033 | -6.91% | |
| Price Multiplier on Financial Quarter End Date | |||||||||
| 31/03/23 | 31/12/22 | 30/09/22 | 30/06/22 | 31/03/22 | 31/12/21 | 30/09/21 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|
| Date | 31/03/23 | 30/12/22 | 30/09/22 | 30/06/22 | 31/03/22 | 31/12/21 | 30/09/21 | - | |
| Price | 2.65 | 2.69 | 2.79 | 2.84 | 2.98 | 2.88 | 3.00 | - | |
| P/RPS | 6.57 | 6.26 | 6.96 | 7.40 | 9.79 | 8.62 | 20.53 | -53.24% | |
| P/EPS | -548.37 | -38.68 | 1,389.56 | -1,482.60 | -133.17 | 93.51 | -58.63 | 344.52% | |
| EY | -0.18 | -2.59 | 0.07 | -0.07 | -0.75 | 1.07 | -1.71 | -77.73% | |
| DY | 0.00 | 3.35 | 0.00 | 2.11 | 0.00 | 3.13 | 0.00 | - | |
| P/NAPS | 1.23 | 1.21 | 1.22 | 1.22 | 1.28 | 1.18 | 1.24 | -0.53% | |
| Price Multiplier on Announcement Date | |||||||||
| 31/03/23 | 31/12/22 | 30/09/22 | 30/06/22 | 31/03/22 | 31/12/21 | 30/09/21 | CAGR | ||
|---|---|---|---|---|---|---|---|---|---|
| Date | 25/05/23 | 23/02/23 | 24/11/22 | 25/08/22 | 26/05/22 | 24/02/22 | 25/11/21 | - | |
| Price | 2.62 | 2.75 | 2.72 | 2.98 | 2.98 | 2.84 | 3.01 | - | |
| P/RPS | 6.50 | 6.40 | 6.78 | 7.76 | 9.79 | 8.50 | 20.59 | -53.66% | |
| P/EPS | -542.17 | -39.54 | 1,354.69 | -1,555.69 | -133.17 | 92.21 | -58.83 | 340.16% | |
| EY | -0.18 | -2.53 | 0.07 | -0.06 | -0.75 | 1.08 | -1.70 | -77.64% | |
| DY | 0.00 | 3.27 | 0.00 | 2.01 | 0.00 | 3.17 | 0.00 | - | |
| P/NAPS | 1.21 | 1.23 | 1.19 | 1.28 | 1.28 | 1.16 | 1.25 | -2.14% | |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Latest Videos
Apps
Top Articles
1
Mercury Securities Research
2
3
THE INVESTMENT APPROACH OF CALVIN TAN
4
Good Articles to Share
5
Good Articles to Share
6
Good Articles to Share
U.S. has pretty good chance to see more white Christmas: forecast
7
Good Articles to Share
U.S. California's population rebounds to near pre-pandemic level
8
Good Articles to Share
U.S. consumers feel less confident as economy concerns mount
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
